|
⚲
|
| Keyboard |
| Kohrs Douglas W
✚
|
|
|---|---|
| CIK # | 0001021425 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001021425] | |
| 4 | [0001021425] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Proto Labs Inc | |
| Kohrs Douglas W | |
| Wright Medical Group NV |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Proto Labs Inc PRLB
Stock Option (right to buy) · derivative
|
2015-05-20 | Grant | 1,609 | $0.00 | |
|
Proto Labs Inc PRLB
Common Stock
|
2015-05-20 | Grant | 715 | $0.00 | |
|
Proto Labs Inc PRLB
Common Stock
|
2014-05-20 | Grant | 798 | $0.00 | |
|
Proto Labs Inc PRLB
Stock Option (right to buy) · derivative
|
2014-05-20 | Grant | 1,731 | $0.00 | |
|
Proto Labs Inc PRLB
Stock Option (right to buy) · derivative
|
2013-05-23 | Grant | 2,500 | $0.00 | |
|
Wright Medical Group NV TRNX
Stock Option (right to buy) · derivative
|
2012-08-10 | Grant | 51,987 | $0.00 | |
|
Wright Medical Group NV TRNX
Ordinary Shares, par value EUR 0.03 per share
|
2012-08-10 | Grant | 23,758 | $0.00 | |
|
Proto Labs Inc PRLB
Common Stock
|
2012-05-07 | Grant | 3,270 | $0.00 | |
|
Proto Labs Inc PRLB
Stock Option (right to buy) · derivative
|
2012-05-07 | Grant | 4,762 | $0.00 |